116 related articles for article (PubMed ID: 7028589)
1. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice.
Flatt PR; Bailey CJ
Horm Metab Res; 1981 Oct; 13(10):556-60. PubMed ID: 7028589
[TBL] [Abstract][Full Text] [Related]
2. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR
Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360
[TBL] [Abstract][Full Text] [Related]
3. Blood glucose and serum insulin levels in lean and genetically obese mice.
Beloff-Chain A; Freund N; Rookledge KA
Horm Metab Res; 1975 Sep; 7(5):374-8. PubMed ID: 1183915
[TBL] [Abstract][Full Text] [Related]
4. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice.
Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH
Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
[TBL] [Abstract][Full Text] [Related]
6. Plasma glucose and insulin response to glucagon and arginine in Aston ob/ob mice: evidence for a selective defect in glucose-mediated insulin release.
Flatt PR; Bailey CJ
Horm Metab Res; 1982 Mar; 14(3):127-30. PubMed ID: 7040198
[TBL] [Abstract][Full Text] [Related]
7. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
Bailey CJ; Flatt PR
Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
[TBL] [Abstract][Full Text] [Related]
8. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
[TBL] [Abstract][Full Text] [Related]
10. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
[TBL] [Abstract][Full Text] [Related]
11. A metabolic profile of fed and fasting genetically obese mice at 4-5 months of age.
Lombardo YB; Hron WT; Sobocinski KA; Menahan LA
Horm Metab Res; 1984 Dec; 16 Suppl 1():37-42. PubMed ID: 6532936
[TBL] [Abstract][Full Text] [Related]
12. Effect of age on hepatocyte and soleus muscle insulin receptor binding in lean and genetically obese diabetic (ob/ob) mice.
Lord JM; Atkins TW
Diabetes Res; 1985 Sep; 2(5):259-65. PubMed ID: 3905189
[TBL] [Abstract][Full Text] [Related]
13. Sources of plasma glucose and liver glycogen in fasted ob/ob mice.
Turner SM; Linfoot PA; Neese RA; Hellerstein MK
Acta Diabetol; 2005 Dec; 42(4):187-93. PubMed ID: 16382307
[TBL] [Abstract][Full Text] [Related]
14. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR
Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice.
Steerenberg PA; Beekhof PK; Feskens EJ; Lips CJ; Höppener JW; Beems RB
Diabetes Nutr Metab; 2002 Aug; 15(4):205-14. PubMed ID: 12416657
[TBL] [Abstract][Full Text] [Related]
16. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
17. Regulation of plasma immunoreactive glucagon in obese hyperglycaemic (ob/ob) mice.
Flatt PR; Bailey CJ; Buchanan KD
J Endocrinol; 1982 Nov; 95(2):215-27. PubMed ID: 6757362
[TBL] [Abstract][Full Text] [Related]
18. The actions of dichloroacetic acid on blood glucose, liver glycogen and fatty acid synthesis in obese-hyperglycaemic (ob/ob) and lean mice.
Enser M; Whittington FM
Horm Metab Res; 1983 May; 15(5):225-9. PubMed ID: 6347856
[TBL] [Abstract][Full Text] [Related]
19. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
[TBL] [Abstract][Full Text] [Related]
20. In vivo knockdown of p85alpha with an antisense oligonucleotide improves insulin sensitivity in Lep(ob/ob) and diet-induced obese mice.
Moriarty MW; McCurdy CE; Janssen RC; Shaw T; Leitner JW; Friedman JE; Draznin B
Horm Metab Res; 2009 Oct; 41(10):757-61. PubMed ID: 19598077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
